← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2008Last known activity
Oct 31, 2022
Timeline
1990s
- Jun 1, 1999
Singapore Clinical Research Institute— Founded
Drugs by trial phase (27 distinct, 22 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Bacteremia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Cardio-Renal Syndrome
- Cognitive Dysfunction
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Fatty Liver
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Inflammation
- Insulin Resistance
- Liver Diseases
- Lung Neoplasms
- Non-alcoholic Fatty Liver Disease
- Schizophrenia
- Severe Acute Respiratory Syndrome
- Syndrome
- Virus Diseases
- Zika Virus Infection
Recent trials (23)
- NCT05516628CollaboratorPhase 2Oct 31, 2022
- NCT05377034CollaboratorPhase 2Aug 25, 2022
- NCT05199324CollaboratorPhase 3Apr 1, 2022
- NCT04746222CollaboratorPhase 2/Phase 3Jul 31, 2021
- NCT04342156CollaboratorPhase 3Apr 30, 2020
- NCT03776695CollaboratorPhase 1Oct 9, 2018
- NCT03443830CollaboratorPhase 1Feb 8, 2018
- NCT03503942CollaboratorN/ADec 30, 2017
- NCT03050476CollaboratorPhase 2/Phase 3Feb 1, 2017
- NCT02811354CollaboratorPhase 2Jun 1, 2016
- NCT02774837CollaboratorPhase 4May 1, 2016
- NCT02409238CollaboratorPhase 4Apr 1, 2015
- NCT02343393CollaboratorPhase 3Jan 1, 2015
- NCT02140996Lead sponsorPhase 1Sep 1, 2014
- NCT03281083CollaboratorPhase 2Mar 28, 2014
Details
- Founded
- Singapore, SG Jun 1, 1999
- Last known activity
- Oct 31, 2022